Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE ARAGO : revenue, balance sheet and financial ratios

PHARMACIE ARAGO is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75013), this company of category PME shows in 2025 a net income positive of 20 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE ARAGO (SIREN 809577091)
Indicator 2025 2024 2023 2022 2021 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 20 363 € 20 449 € 25 463 € 136 761 € 94 589 € 50 151 € 64 408 € 68 916 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE ARAGO generates positive net income of 20 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 69 k€ -> 20 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

20 363 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

20.613%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

62.741%

Solvency indicators evolution
PHARMACIE ARAGO

Sector positioning

Debt ratio
20.61 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good -11 pts over 3 years

In 2025, the debt ratio of PHARMACIE ARAGO (20.61) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
62.74% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good +6 pts over 3 years

In 2025, the financial autonomy of PHARMACIE ARAGO (62.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Positioning of PHARMACIE ARAGO in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE ARAGO is estimated at 323 468 € (range 219 507€ - 507 566€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
219k€ 323k€ 507k€
323 468 € Range: 219 507€ - 507 566€
NAF 5 année 2025

Valuation method used

Net Income Multiple
20 363 € × 15.9x = 323 469 €
Range: 219 507€ - 507 567€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE ARAGO with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE ARAGO

What is the revenue of PHARMACIE ARAGO ?

The revenue of PHARMACIE ARAGO is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE ARAGO profitable?

Yes, PHARMACIE ARAGO generated a net profit of 20 k€ in 2025.

Where is the headquarters of PHARMACIE ARAGO ?

The headquarters of PHARMACIE ARAGO is located in PARIS (75013), in the department Paris.

Where to find the tax return of PHARMACIE ARAGO ?

The tax return of PHARMACIE ARAGO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE ARAGO operate?

PHARMACIE ARAGO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.